- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on HER2 Positive Advanced Solid Tumors in South Africa
Total 587 results
-
Millennium Pharmaceuticals, Inc.TerminatedAdvanced Malignant Solid TumorsUnited States
-
BeiGeneRecruitingAdvanced Solid TumorAustralia
-
Adagene IncRecruitingAdvanced/Metastatic Solid TumorsSingapore, Australia, United States
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingLocally Advanced Unresectable or Metastatic Solid TumorsAustralia
-
BeiGeneRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Hormone-receptor-positive...Australia, United States
-
Eucure (Beijing) Biopharma Co., LtdCompletedAdvanced Solid TumorAustralia
-
Stingray TherapeuticsRecruitingAdvanced / Metastatic Solid TumorAustralia
-
Jazz PharmaceuticalsCompletedAdvanced Solid Tumor | Metastatic Solid Tumor | Urothelial Cancer | Poorly Differentiated Neuroendocrine Carcinomas | Homologous Recombination Deficient-Positive Malignancies AgnosticUnited States
-
BeiGeneRecruitingSolid Tumor | Advanced Solid Tumor | Metastatic Solid TumorUnited States, France, Australia
-
Antengene Therapeutics LimitedMerck Sharp & Dohme LLCRecruitingLocally Advanced or Metastatic Solid TumorsAustralia, China
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsUnited States, United Kingdom, Italy
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingLocally Advanced Unresectable or Metastatic Solid TumorsAustralia
-
Shanghai Best-Link Bioscience, LLCRecruitingAdvanced Solid TumorChina, Australia
-
Shanghai Henlius BiotechCompletedAdvanced Solid TumorsAustralia
-
Spago Nanomedical ABRecruitingSolid Tumor | Metastatic Cancer | Refractory Cancer | Locally Advanced Solid Tumor | Unresectable Solid Tumor | Recurrent Solid TumorAustralia
-
Arcus Biosciences, Inc.Gilead Sciences; Strata OncologyActive, not recruitingAdvanced Solid TumorsUnited States
-
AmgenCompletedAdvanced Solid TumorsUnited States, Belgium, Spain, Australia
-
Eli Lilly and CompanyTerminated
-
PfizerKyowa Kirin Co., Ltd.TerminatedAdvanced/Metastatic Solid TumorsUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedAdvanced Solid TumorsSpain, United States, Netherlands, Hungary, Italy, France, Belgium
-
D3 Bio (Wuxi) Co., LtdRecruitingAdvanced Solid Tumors With MAPK Pathway MutationsAustralia, China, United States
-
Eisai Inc.Completed
-
AmgenRecruitingAdvanced Solid TumorsUnited States, Korea, Republic of, Spain, Australia, Germany, France, Japan, Canada
-
Cullinan Oncology Inc.Harbour BioMed US, Inc.Recruiting
-
Sumitomo Pharma America, Inc.CompletedCancer, Advanced Solid TumorsUnited States, Canada
-
Eucure (Beijing) Biopharma Co., LtdRecruitingAdvanced Solid TumorChina, Australia
-
SelecxineRecruitingAdvanced Solid TumorUnited States, Australia, Korea, Republic of
-
BeiGeneRecruitingAdvanced Solid TumorChina, United States, Australia, New Zealand, Korea, Republic of
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Germany, Italy, United Kingdom, Belgium, Canada, Korea, Republic of, Taiwan, France
-
Shanghai Henlius BiotechWithdrawnAdvanced Solid TumorUnited States
-
Bien-Willner Physicians Group PANo One Left Alone; Carolina Blood and Cancer Care AssociatesNot yet recruitingAdvanced Cancer | Myeloid Malignancy | Solid Tumor, AdultUnited States
-
Shanghai EpimAb Biotherapeutics Co., Ltd.TerminatedAdvanced Solid TumorsChina, Australia, United States
-
Synnovation Therapeutics, Inc.Recruiting
-
Harbour BioMed US, Inc.CompletedAdvanced Solid TumorAustralia, China, Hong Kong
-
Bristol-Myers SquibbRecruitingAdvanced Solid TumorsCanada, United States, Argentina, France, Spain, Italy, Australia, Mexico, Chile
-
ModernaTX, Inc.RecruitingAdvanced Solid TumorsUnited States, United Kingdom, Australia, Spain
-
Fujifilm Pharmaceuticals U.S.A., Inc.Merck Sharp & Dohme LLCRecruitingAdvanced Solid TumorUnited States
-
Aadi Bioscience, Inc.Active, not recruitingMalignant Solid Neoplasm | Neoplasms | Cancer | Neoplasm Metastasis | Solid Tumor | Metastatic Cancer | Metastasis | Advanced Solid Tumor | Metastatic Solid Tumor | Advanced Cancer | Tumor | Malignant Neoplasm | Malignant Tumor | Tumors | Cancer Metastatic | Tumor, Solid | Malignant Solid Tumor | TSC | TSC1 | TSC2 | Metastatic NeoplasmUnited States, Korea, Republic of, Puerto Rico
-
Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Australia, Canada, Chile, China, France, Greece, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, South Africa, Spain, Sweden
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorUnited States
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorCanada, United States, Korea, Republic of, Taiwan, Spain, Australia, Belgium, France, Netherlands, Singapore, Germany
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Germany, Spain, Canada, France, Korea, Republic of, Israel, Netherlands, United Kingdom
-
Merck Sharp & Dohme LLCRecruitingAdvanced Solid TumorsChina, United States, Australia, Canada, Chile, Israel, Japan, Korea, Republic of, Panama, Poland, Spain, Switzerland, Turkey, New Zealand, Taiwan, Denmark
-
Merck Sharp & Dohme LLCActive, not recruitingAdvanced or Metastatic Solid TumorsChile, Hungary, Korea, Republic of, South Africa, Spain, Japan
-
Gilead SciencesRecruitingAdvanced Solid TumorUnited States, Australia, Taiwan, Spain, Canada
-
BeiGeneCompletedFor Participants With Advanced Solid Tumors Failed With Previous Lines of TreatmentAustralia
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompleted
-
AmgenActive, not recruitingKRAS p.G12C Mutant Advanced Solid TumorsUnited States, France, Canada, Spain, Belgium, Korea, Republic of, Austria, Australia, Hungary, Greece, Germany, Japan, Romania, Switzerland, Brazil, Portugal
-
AstraZenecaCompletedAdvanced Solid Malignancies | Breast Cancer - ER+, HER2 - | Breast Cancer - ER+, HER2-, PIK3CA Gene MutationUnited States, United Kingdom